# Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases

> **NCT04812470** · PHASE1 · COMPLETED · sponsor: **Vastra Gotaland Region** · enrollment: 8 (actual)

## Conditions studied

- Metastatic Uveal Melanoma
- Metastatic Cutaneous Melanoma

## Interventions

- **DRUG:** Autologous Tumor Infiltrating Lymphocytes
- **DRUG:** Melphalan
- **DRUG:** Interleukin-2

## Key facts

- **NCT ID:** NCT04812470
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-06
- **Primary completion:** 2025-05-26
- **Final completion:** 2025-05-26
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04812470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04812470, "Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04812470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*